10 results
Progression-free Survival  #EBM #Honc #Osimertinib #NSCLC #Survival #NEJM
Progression-free Survival #EBM ... #Honc #Osimertinib ... #NSCLC #Survival
Alectinib versus Crizotinib in Untreated ALK-Positive Non–Small-Cell Lung Cancer #EBM #Honc #Alectinib #Crizotinib #ALK #ALKPositive #NSCLC
Non–Small-Cell Lung Cancer #EBM ... #Honc #Alectinib ... #ALKPositive #NSCLC
Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer - Progression-free Survival in the Intention-to-Treat Population.
#EBM #Honc #PACIFIC ... #Durvalumab #NSCLC
Validation of the “Step-by-Step” Approach in the Management of Young Febrile Infants
Visual Abstract by Dr. Kirsty
pubmed/27382134 #EBM ... #Peds #Pediatrics ... Febrile #Infant #Risk
PocketPEM - BRUE - Brief Resolved Unexplained Events #Diagnosis #Management #Peds #EM #BRUE #Risk #PocketCard #PocketPEM
Diagnosis #Management #Peds ... #EM #BRUE #Risk
Decision Aid - What is the risk of serious infection in febrile infants (<60 days old)?

Reference:
- What is the risk ... Febrile #Infant #Peds ... #Stewardship #EBM ... Serious #Infection #Risk
IgM and Non-IgM - Risk and Type of Progression #EBM #Honc #MGUS #Progression #IgM #NonIgM #MultipleMyeloma
and Non-IgM - Risk ... of Progression #EBM ... #Honc #MGUS #Progression
Cumulative Incidence of Progression of MGUS, with Death Accounted for as a Competing Risk #EBM #Honc
as a Competing Risk ... #EBM #Honc #MGUS
PARIS Trial: A Randomized Trial of High-Flow Oxygen Therapy in Infants with Bronchiolitis
#EBM #Peds #Pediatrics #Bronchiolitis
Bronchiolitis #EBM ... #Peds #Pediatrics ... HighFlowNasalCannula #HFNC
The Febrile Infant Step-by-Step Algorithm
This is an algorithm developed by European emergency physicians to identify low-risk
to identify low-risk ... 46.9% #Diagnosis #EBM ... Management #Pediatrics #Peds ... #Antibiotics #Risk